Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Population Groups × Clear all

Phase

Phase NA 3 Phase 2 2 Phase 1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 114 Radiotherapy 87 Carboplatin 71 Paclitaxel 69 Cyclophosphamide 68 Fluorouracil 66 Gemcitabine 60 Docetaxel 60 Capecitabine 58 Oxaliplatin 53 Etoposide 52 Doxorubicin 50 Vincristine 40 Leucovorin 38 Chemotherapy, Adjuvant 35 Cytarabine 34 Drug Therapy 29 Dexamethasone 29 Epirubicin 25 Bevacizumab 23 Pemetrexed 22 Prednisone 21 Irinotecan 21 Tamoxifen 20 Neoadjuvant Therapy 19 Rituximab 18 Radiotherapy, Intensity-Modulated 18 Methotrexate 18 apatinib 17 Vinorelbine 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01536223 2013-03-05

ESNCCT

Zhejiang Cancer Hospital

Phase 3 Unknown

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡